Global Conjugate Vaccine Market Growth 2022-2028
As the global economy mends, the 2021 growth of Conjugate Vaccine will have significant change from previous year. According to our latest study, the global Conjugate Vaccine market size is USD million in 2022 from USD 9777.7 million in 2021, with a change of % between 2021 and 2022. The global Conjugate Vaccine market size will reach USD 12290 million in 2028, growing at a CAGR of 3.3% over the analysis period.
The United States Conjugate Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Conjugate Vaccine market, reaching US$ million by the year 2028. As for the Europe Conjugate Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Conjugate Vaccine players cover Pfizer, GSK, Sanofi, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Conjugate Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Children
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Conjugate Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Conjugate Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Conjugate Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Conjugate Vaccine Segment by Type
2.2.1 Hib Vaccine
2.2.2 Meningococcal Vaccine
2.2.3 Pneumococcal Vaccine
2.2.4 Others
2.3 Conjugate Vaccine Sales by Type
2.3.1 Global Conjugate Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Conjugate Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Conjugate Vaccine Sale Price by Type (2017-2022)
2.4 Conjugate Vaccine Segment by End Users
2.4.1 Children
2.4.2 Adult
2.5 Conjugate Vaccine Sales by End Users
2.5.1 Global Conjugate Vaccine Sale Market Share by End Users (2017-2022)
2.5.2 Global Conjugate Vaccine Revenue and Market Share by End Users (2017-2022)
2.5.3 Global Conjugate Vaccine Sale Price by End Users (2017-2022)
3 Global Conjugate Vaccine by Company
3.1 Global Conjugate Vaccine Breakdown Data by Company
3.1.1 Global Conjugate Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Conjugate Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Conjugate Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Conjugate Vaccine Revenue by Company (2020-2022)
3.2.2 Global Conjugate Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Conjugate Vaccine Sale Price by Company
3.4 Key Manufacturers Conjugate Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Conjugate Vaccine Product Location Distribution
3.4.2 Players Conjugate Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Conjugate Vaccine by Geographic Region
4.1 World Historic Conjugate Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Conjugate Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Conjugate Vaccine Annual Revenue by Geographic Region
4.2 World Historic Conjugate Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Conjugate Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Conjugate Vaccine Annual Revenue by Country/Region
4.3 Americas Conjugate Vaccine Sales Growth
4.4 APAC Conjugate Vaccine Sales Growth
4.5 Europe Conjugate Vaccine Sales Growth
4.6 Middle East & Africa Conjugate Vaccine Sales Growth
5 Americas
5.1 Americas Conjugate Vaccine Sales by Country
5.1.1 Americas Conjugate Vaccine Sales by Country (2017-2022)
5.1.2 Americas Conjugate Vaccine Revenue by Country (2017-2022)
5.2 Americas Conjugate Vaccine Sales by Type
5.3 Americas Conjugate Vaccine Sales by End Users
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Conjugate Vaccine Sales by Region
6.1.1 APAC Conjugate Vaccine Sales by Region (2017-2022)
6.1.2 APAC Conjugate Vaccine Revenue by Region (2017-2022)
6.2 APAC Conjugate Vaccine Sales by Type
6.3 APAC Conjugate Vaccine Sales by End Users
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Conjugate Vaccine by Country
7.1.1 Europe Conjugate Vaccine Sales by Country (2017-2022)
7.1.2 Europe Conjugate Vaccine Revenue by Country (2017-2022)
7.2 Europe Conjugate Vaccine Sales by Type
7.3 Europe Conjugate Vaccine Sales by End Users
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Conjugate Vaccine by Country
8.1.1 Middle East & Africa Conjugate Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Conjugate Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Conjugate Vaccine Sales by Type
8.3 Middle East & Africa Conjugate Vaccine Sales by End Users
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Conjugate Vaccine
10.3 Manufacturing Process Analysis of Conjugate Vaccine
10.4 Industry Chain Structure of Conjugate Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Conjugate Vaccine Distributors
11.3 Conjugate Vaccine Customer
12 World Forecast Review for Conjugate Vaccine by Geographic Region
12.1 Global Conjugate Vaccine Market Size Forecast by Region
12.1.1 Global Conjugate Vaccine Forecast by Region (2023-2028)
12.1.2 Global Conjugate Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Conjugate Vaccine Forecast by Type
12.7 Global Conjugate Vaccine Forecast by End Users
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Conjugate Vaccine Product Offered
13.1.3 Pfizer Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Conjugate Vaccine Product Offered
13.2.3 GSK Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Conjugate Vaccine Product Offered
13.3.3 Sanofi Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Conjugate Vaccine Product Offered
13.4.3 Merck Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Walvax Biotechnology
13.5.1 Walvax Biotechnology Company Information
13.5.2 Walvax Biotechnology Conjugate Vaccine Product Offered
13.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Walvax Biotechnology Main Business Overview
13.5.5 Walvax Biotechnology Latest Developments
13.6 Royal (Wuxi) Bio-Pharmaceutical
13.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
13.6.2 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Offered
13.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Royal (Wuxi) Bio-Pharmaceutical Main Business Overview
13.6.5 Royal (Wuxi) Bio-Pharmaceutical Latest Developments
13.7 Bharat Biotech
13.7.1 Bharat Biotech Company Information
13.7.2 Bharat Biotech Conjugate Vaccine Product Offered
13.7.3 Bharat Biotech Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bharat Biotech Main Business Overview
13.7.5 Bharat Biotech Latest Developments
13.8 Zhifei Biologic
13.8.1 Zhifei Biologic Company Information
13.8.2 Zhifei Biologic Conjugate Vaccine Product Offered
13.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Zhifei Biologic Main Business Overview
13.8.5 Zhifei Biologic Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Conjugate Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Conjugate Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Hib Vaccine
Table 4. Major Players of Meningococcal Vaccine
Table 5. Major Players of Pneumococcal Vaccine
Table 6. Major Players of Others
Table 7. Global Conjugate Vaccine Sales by Type (2017-2022) & (Million Unit)
Table 8. Global Conjugate Vaccine Sales Market Share by Type (2017-2022)
Table 9. Global Conjugate Vaccine Revenue by Type (2017-2022) & ($ million)
Table 10. Global Conjugate Vaccine Revenue Market Share by Type (2017-2022)
Table 11. Global Conjugate Vaccine Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Conjugate Vaccine Sales by End Users (2017-2022) & (Million Unit)
Table 13. Global Conjugate Vaccine Sales Market Share by End Users (2017-2022)
Table 14. Global Conjugate Vaccine Revenue by End Users (2017-2022)
Table 15. Global Conjugate Vaccine Revenue Market Share by End Users (2017-2022)
Table 16. Global Conjugate Vaccine Sale Price by End Users (2017-2022) & (USD/Unit)
Table 17. Global Conjugate Vaccine Sales by Company (2020-2022) & (Million Unit)
Table 18. Global Conjugate Vaccine Sales Market Share by Company (2020-2022)
Table 19. Global Conjugate Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Conjugate Vaccine Revenue Market Share by Company (2020-2022)
Table 21. Global Conjugate Vaccine Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Conjugate Vaccine Producing Area Distribution and Sales Area
Table 23. Players Conjugate Vaccine Products Offered
Table 24. Conjugate Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Conjugate Vaccine Sales by Geographic Region (2017-2022) & (Million Unit)
Table 28. Global Conjugate Vaccine Sales Market Share Geographic Region (2017-2022)
Table 29. Global Conjugate Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Conjugate Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Conjugate Vaccine Sales by Country/Region (2017-2022) & (Million Unit)
Table 32. Global Conjugate Vaccine Sales Market Share by Country/Region (2017-2022)
Table 33. Global Conjugate Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Conjugate Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Conjugate Vaccine Sales by Country (2017-2022) & (Million Unit)
Table 36. Americas Conjugate Vaccine Sales Market Share by Country (2017-2022)
Table 37. Americas Conjugate Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Conjugate Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Americas Conjugate Vaccine Sales by Type (2017-2022) & (Million Unit)
Table 40. Americas Conjugate Vaccine Sales Market Share by Type (2017-2022)
Table 41. Americas Conjugate Vaccine Sales by End Users (2017-2022) & (Million Unit)
Table 42. Americas Conjugate Vaccine Sales Market Share by End Users (2017-2022)
Table 43. APAC Conjugate Vaccine Sales by Region (2017-2022) & (Million Unit)
Table 44. APAC Conjugate Vaccine Sales Market Share by Region (2017-2022)
Table 45. APAC Conjugate Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Conjugate Vaccine Revenue Market Share by Region (2017-2022)
Table 47. APAC Conjugate Vaccine Sales by Type (2017-2022) & (Million Unit)
Table 48. APAC Conjugate Vaccine Sales Market Share by Type (2017-2022)
Table 49. APAC Conjugate Vaccine Sales by End Users (2017-2022) & (Million Unit)
Table 50. APAC Conjugate Vaccine Sales Market Share by End Users (2017-2022)
Table 51. Europe Conjugate Vaccine Sales by Country (2017-2022) & (Million Unit)
Table 52. Europe Conjugate Vaccine Sales Market Share by Country (2017-2022)
Table 53. Europe Conjugate Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Conjugate Vaccine Revenue Market Share by Country (2017-2022)
Table 55. Europe Conjugate Vaccine Sales by Type (2017-2022) & (Million Unit)
Table 56. Europe Conjugate Vaccine Sales Market Share by Type (2017-2022)
Table 57. Europe Conjugate Vaccine Sales by End Users (2017-2022) & (Million Unit)
Table 58. Europe Conjugate Vaccine Sales Market Share by End Users (2017-2022)
Table 59. Middle East & Africa Conjugate Vaccine Sales by Country (2017-2022) & (Million Unit)
Table 60. Middle East & Africa Conjugate Vaccine Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Conjugate Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Conjugate Vaccine Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Conjugate Vaccine Sales by Type (2017-2022) & (Million Unit)
Table 64. Middle East & Africa Conjugate Vaccine Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Conjugate Vaccine Sales by End Users (2017-2022) & (Million Unit)
Table 66. Middle East & Africa Conjugate Vaccine Sales Market Share by End Users (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Conjugate Vaccine
Table 68. Key Market Challenges & Risks of Conjugate Vaccine
Table 69. Key Industry Trends of Conjugate Vaccine
Table 70. Conjugate Vaccine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Conjugate Vaccine Distributors List
Table 73. Conjugate Vaccine Customer List
Table 74. Global Conjugate Vaccine Sales Forecast by Region (2023-2028) & (Million Unit)
Table 75. Global Conjugate Vaccine Sales Market Forecast by Region
Table 76. Global Conjugate Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Conjugate Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Conjugate Vaccine Sales Forecast by Country (2023-2028) & (Million Unit)
Table 79. Americas Conjugate Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Conjugate Vaccine Sales Forecast by Region (2023-2028) & (Million Unit)
Table 81. APAC Conjugate Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Conjugate Vaccine Sales Forecast by Country (2023-2028) & (Million Unit)
Table 83. Europe Conjugate Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Conjugate Vaccine Sales Forecast by Country (2023-2028) & (Million Unit)
Table 85. Middle East & Africa Conjugate Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Conjugate Vaccine Sales Forecast by Type (2023-2028) & (Million Unit)
Table 87. Global Conjugate Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Conjugate Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Conjugate Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Conjugate Vaccine Sales Forecast by End Users (2023-2028) & (Million Unit)
Table 91. Global Conjugate Vaccine Sales Market Share Forecast by End Users (2023-2028)
Table 92. Global Conjugate Vaccine Revenue Forecast by End Users (2023-2028) & ($ Millions)
Table 93. Global Conjugate Vaccine Revenue Market Share Forecast by End Users (2023-2028)
Table 94. Pfizer Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Conjugate Vaccine Product Offered
Table 96. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. GSK Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. GSK Conjugate Vaccine Product Offered
Table 101. GSK Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. GSK Main Business
Table 103. GSK Latest Developments
Table 104. Sanofi Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanofi Conjugate Vaccine Product Offered
Table 106. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Sanofi Main Business
Table 108. Sanofi Latest Developments
Table 109. Merck Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Merck Conjugate Vaccine Product Offered
Table 111. Merck Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. Merck Main Business
Table 113. Merck Latest Developments
Table 114. Walvax Biotechnology Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Walvax Biotechnology Conjugate Vaccine Product Offered
Table 116. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. Walvax Biotechnology Main Business
Table 118. Walvax Biotechnology Latest Developments
Table 119. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Offered
Table 121. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. Royal (Wuxi) Bio-Pharmaceutical Main Business
Table 123. Royal (Wuxi) Bio-Pharmaceutical Latest Developments
Table 124. Bharat Biotech Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Bharat Biotech Conjugate Vaccine Product Offered
Table 126. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. Bharat Biotech Main Business
Table 128. Bharat Biotech Latest Developments
Table 129. Zhifei Biologic Basic Information, Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Zhifei Biologic Conjugate Vaccine Product Offered
Table 131. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. Zhifei Biologic Main Business
Table 133. Zhifei Biologic Latest Developments
List of Figures
Figure 1. Picture of Conjugate Vaccine
Figure 2. Conjugate Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Conjugate Vaccine Sales Growth Rate 2017-2028 (Million Unit)
Figure 7. Global Conjugate Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Conjugate Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Hib Vaccine
Figure 10. Product Picture of Meningococcal Vaccine
Figure 11. Product Picture of Pneumococcal Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Conjugate Vaccine Sales Market Share by Type in 2021
Figure 14. Global Conjugate Vaccine Revenue Market Share by Type (2017-2022)
Figure 15. Conjugate Vaccine Consumed in Children
Figure 16. Global Conjugate Vaccine Market: Children (2017-2022) & (Million Unit)
Figure 17. Conjugate Vaccine Consumed in Adult
Figure 18. Global Conjugate Vaccine Market: Adult (2017-2022) & (Million Unit)
Figure 19. Global Conjugate Vaccine Sales Market Share by End Users (2017-2022)
Figure 20. Global Conjugate Vaccine Revenue Market Share by End Users in 2021
Figure 21. Conjugate Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Conjugate Vaccine Revenue Market Share by Company in 2021
Figure 23. Global Conjugate Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Conjugate Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Conjugate Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global Conjugate Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Conjugate Vaccine Sales 2017-2022 (Million Unit)
Figure 28. Americas Conjugate Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Conjugate Vaccine Sales 2017-2022 (Million Unit)
Figure 30. APAC Conjugate Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Conjugate Vaccine Sales 2017-2022 (Million Unit)
Figure 32. Europe Conjugate Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Conjugate Vaccine Sales 2017-2022 (Million Unit)
Figure 34. Middle East & Africa Conjugate Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Conjugate Vaccine Sales Market Share by Country in 2021
Figure 36. Americas Conjugate Vaccine Revenue Market Share by Country in 2021
Figure 37. United States Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Conjugate Vaccine Sales Market Share by Region in 2021
Figure 42. APAC Conjugate Vaccine Revenue Market Share by Regions in 2021
Figure 43. China Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Conjugate Vaccine Sales Market Share by Country in 2021
Figure 50. Europe Conjugate Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Conjugate Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Conjugate Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Conjugate Vaccine in 2021
Figure 64. Manufacturing Process Analysis of Conjugate Vaccine
Figure 65. Industry Chain Structure of Conjugate Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
